Bosch-Barrera, J.; Martin-Castillo, B.; Buxó, M.; Brunet, J.; Encinar, J.A.; Menendez, J.A.
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. J. Clin. Med. 2020, 9, 1770.
https://doi.org/10.3390/jcm9061770
AMA Style
Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA.
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. Journal of Clinical Medicine. 2020; 9(6):1770.
https://doi.org/10.3390/jcm9061770
Chicago/Turabian Style
Bosch-Barrera, Joaquim, Begoña Martin-Castillo, Maria Buxó, Joan Brunet, José Antonio Encinar, and Javier A. Menendez.
2020. "Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients" Journal of Clinical Medicine 9, no. 6: 1770.
https://doi.org/10.3390/jcm9061770
APA Style
Bosch-Barrera, J., Martin-Castillo, B., Buxó, M., Brunet, J., Encinar, J. A., & Menendez, J. A.
(2020). Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. Journal of Clinical Medicine, 9(6), 1770.
https://doi.org/10.3390/jcm9061770